U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
- Monday, July 11, 2022, 7:14
- PR Newswire
- Add a comment
Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md., July 11, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing…
About the Author
admin has written 21643 stories on this site.